Stories Library

We proudly offer support and resources to researchers, healthcare providers, patients and their advocates as well as our local communities.

December 21, 2021

Paving the Way for a Better Workplace, Better Science, and a Better World

By: Smita Pillai, Chief Diversity, Equity and Inclusion Officer

Regeneron’s first Chief Diversity, Equity & Inclusion (DEI) Officer, Smita Pillai, explains how leadership through action is ensuring our presence in biotech is mindful, equitable and intersectional.

Responsibility & Culture

November 09, 2021

Helping the several million immuno­compromised Americans who are still “Prisoners of the Pandemic”

By: George D. Yancopoulos, MD, PhD, Co-founder, President and Chief Scientific Officer of Regeneron

Regeneron has received numerous queries about making our REGEN-COV® (casirivimab and imdevimab) antibody cocktail available to protect immuno­compromised individuals who do not respond to COVID19 vaccines. This blog reflects our thinking and the current scientific evidence related to this question.

Responsibility & Culture

October 01, 2021

Staying Safe through Science

By: Elizabeth Green, Senior Director, Environment, Health & Safety

Learn about Regeneron's Environment Health & Safety (EH&S) team and how it navigates a constantly changing business environment.

Responsibility & Culture

August 01, 2021

Moving at Pandemic Speed

Rapid response to infectious diseases.

Clinical Research & Medicines

July 06, 2021

A New Breakthrough in the Search for Protective Genetics – and the Medicines That Mimic Them

By: Aris Baras, MD, Senior Vice President and Head of the Regeneron Genetics Center

Learn more about protective genetic variants and the Regeneron Genetics Center's discovery of the GPR75 protective gene associated with reduced body weight and obesity risk.

Genetics

June 15, 2021

Data Privacy Is in Our DNA

By: Ericka Watson, Chief Privacy Officer

Learn more about the importance of data privacy and how Regeneron works to safeguard personal data, including genetic data. See our Data Privacy Philosophy for more information.

Responsibility & Culture

December 02, 2020

Two Targets May Be Better Than One

By: Israel Lowy, MD, PHD, Senior Vice President, Translational and Clinical Sciences, Oncology
Andres Sirulnik, MD, PHD, Senior Vice President, Translational and Clinical Sciences, Hematology

Regeneron leaders Andres Sirulnik and Israel Lowy discuss why they believe bispecific antibodies may be the next class of medicines to revolutionize cancer treatment.

Clinical Research & Medicines, Research & Preclinical Development

November 22, 2020

Chatting With Young Scientists

By: Erin Oswald, Senior Research and Development Specialist, Regeneron
Contributors: Lillian Kay Peterson, Regeneron Science Talent Search 2020 1st place winner, Harvard University undergraduate student
Anaiah Thomas, Regeneron Science Talent Search 2020 5th place winner, Harvard University undergraduate student

Regeneron is committed to fostering the next generation of scientific innovators who can solve society's greatest challenges. Hear from our own research scientist as she discusses career paths in science with two winners of the 2020 Regeneron Science Talent Search.

Responsibility & Culture

November 21, 2020

The Regeneron Journey: 2020 Edition

By: Len Schleifer, MD, PhD, President and Chief Executive Officer

Following an Emergency Use Authorization for casirivimab and imdevimab, Len Schleifer, MD, PhD, Founder and CEO, reflects on what the Regeneron team has accomplished so far in 2020.

Clinical Research & Medicines

October 02, 2020

Advancing our commitment to diversity, equity & inclusion

By: Maya Bermingham, Interim Head of DE&I; Vice President, Government Affairs and Public Policy

Find out how Regeneron is fostering diversity, equity and inclusion in the workplace and communities to extend our mission to improve lives.

Responsibility & Culture